Table 3.

Assessment of safety and feasibility.

Measures	Time of collection
Feasibility—recruitment and completion
Referred patients	Trial completion
Eligible patients	Trial completion
Enrolled patients	Trial completion
Trial completion	Trial completion
Patient withdrawals	Trial completion
Patient dropouts	Trial completion
Feasibility—programme tolerance
Pre-sessional and post-sessional exhaustion, pain and dyspnoea	At each exercise session
ECG recordings	At each exercise session
Feasibility—programme adherence
Number of completed sessions	Trial completion
Time/sets completed in each session	At each exercise session
Patient safety
Number of adverse events	Once weekly and 3-month follow-up
Number of severe adverse events	Once weekly and 3-month follow-up
Hospital admissions/days of hospitalisation	Once weekly and 3-months follow-up